1gG /transferrin receptor fusion protein
US6225448A · kind A · utility
13Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2000 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | May 2, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2510/02
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
This invention provides cells containing recombinant polynucleotides coding for cell surface molecules that, when expressed in the cell, result in rejection of the cell by the host immune system. The invention also provides methods of using such cells, and capsules for delivery of biologically active molecules to a patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.